Late-stage trial shows Russian Covid-19 vaccine to be highly effective

Madrid, Feb 2 (EFE).- Provisional date from the phase III trial of Russia's Covid-19 vaccine, Sputnik V, suggests that a two-dose regimen offers 91.6% efficacy against symptomatic infections, a...

Metadata

Date: 02/02/2021 16:17 (UTC)
Credit: EFE
Source: EFE
Topic: Health » Preventative medicine » Vaccines
Reference: 181000164810
Relevance: Normal

Content included in the following products:

Efedata

Product Suggestions

Multimedia

Contenidos digitales general multimedia América

Text

EFE International News

Photo

EFE Photo

Photo

Gráfico general y gráfico territorial EUA-Caribe.

Photo

Gráfico general América

Video

EFE VÍDEO

Stories

Reportajes general América

Text

EFE News Latino